 Links |
|
|
|
 |
 Videos |
|
|
|
|
 Blogs |
|
|
|
|
 News |
|
|
|
|
 Articles |
|
|
|
|
| In The News |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology
|
|
Bookmark and share this category:
|
News
| Scientists deploy genetics in search for bigfoot |
LONDON (Reuters) - Scientists are turning to genetic testing to see if they can prove the existence of the elusive hairy humanoid known across the world as bigfoot, yeti and sasquatch. A joint project between Oxford University and Switzerland's Lausanne Museum of Zoology will examine organic remains that some say belong to the creature that has been spotted in remote areas for decades. "It's an area that any serious academic ventures into with a deal of trepidation ... It's full of eccentric and downright misleading reports," said Bryan Sykes at Oxford's Wolfson College. ...
Rating: 0.00 (0 votes) |
|
|
| Scientists deploy genetics in search for bigfoot |
 Click here for all details, rating, and other features |
LONDON (Reuters) - Scientists are turning to genetic testing to see if they can prove the existence of the elusive hairy humanoid known across the world as bigfoot, yeti and sasquatch. A joint project between Oxford University and Switzerland's Lausanne Museum of Zoology will examine organic remains that some say belong to the creature that has been spotted in remote areas for decades. "It's an area that any serious academic ventures into with a deal of trepidation ... It's full of eccentric and downright misleading reports," said Bryan Sykes at Oxford's Wolfson College. ...
Rating: 0.00 (0 votes)
|
|
Created: 05/23/2012
Readers this month: 0 - Readers total: 0::
|
Tags:  Scientists deploy genetics search for bigfoot |
|
|
|
| |
| |
|
| Canada OKs Osiris drug; first stem cell therapy |
BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announced. Graft versus host disease (GvHD) is a potentially deadly complication from a bone marrow transplant, when newly implanted cells attack the patient's body. ...
Rating: 0.00 (0 votes) |
|
|
|
| Canada OKs Osiris drug; first stem cell therapy |
BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announced. Graft versus host disease (GvHD) is a potentially deadly complication from a bone marrow transplant, when newly implanted cells attack the patient's body. ...
Rating: 0.00 (0 votes) |
|
|
| |
|
| Study unpicks gene changes behind breast cancer |
 LONDON (Reuters) - Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future. The research, the first of its kind, untangles the genetic history of how cancer evolves, allowing scientists to identify mutational patterns that fuel the growth of breast tumors, and start to work out the processes behind them. ...
Rating: 0.00 (0 votes) |
|
|
| |
| |
| |
|
|
